Population Health Research Institute, McMaster University-Hamilton Health Sciences, Hamilton, ON L8L 2X2, Canada.BACKGROUND: Tobacco use is one of the major avoidable causes of cardiovasc.....
Department of Medicine, McMaster University, and Population Health Research Institute, Hamilton General Hospital, Hamilton, Canada. yusufs@mcmaster.caBACKGROUND: Approximately 15.5 million deaths from cardiovascular.....
相关链接:PDF全文 Background A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the infa.....
Context The benefit of clopidogrel pretreatment before percutaneous coronary intervention (PCI) remains debated and its use has not been universally adopted.Objective: To determine if clopidogrel pretreatment before PCI .....
JAMA. 2005;293:437-446. The CREATE-ECLA Trial Group Investigators Context: Glucose-insulin-potassium (GIK) infusion is a widely applicable, low-cost therapy that has been postulated to improve mortality in patients wit.....
JAMA. 2005;293:427-435. The CREATE Trial Group Investigators Context: Although reperfusion therapy, aspirin, -blockers, and angiotensin-converting enzyme inhibitors reduce mortality when used early in patients with a.....
N Engl J Med. 2003 Nov 13;349(20):1893-906. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or.....